The benefits of automating a medical research lab include sifting through massive amounts of data in a short period of time.

Why I Automate – This Robot is Changing How We Cure Diseases

Contributed by | The Association for Advancing Automation (A3)

 

Scientists at a National Institutes of Health laboratory search for the right combinations of chemicals to fight diseases. In this next installment in the “Why I Automate” series, researcher Chris Austin describes how robots can test millions of potential drug combinations that would overwhelm human capabilities.

There are 7,000 known diseases but medicines exist to battle only 500 of those illnesses. The laboratory programmed robots that are traditionally used in the manufacturing space, but specially engineered to work in a clean laboratory environment. They handle plates with diseased cells and test against 450,000 different chemical combinations to find solutions. Not one of the tests is duplicated and this shows how automated equipment can learn to handle unique data.

Automated equipment in labs can work without harm near biological contaminants, radioactive material, and toxic chemotherapy compounds. Companies in all industries handling hazardous materials can automate and make more strategic use of people and keep them safe.

In the video clip, Mr. Austin describes a critical moment in the testing of leukemia cells and how the automated process uncovered a solution available to people in months that would have taken researchers years to discover:

 

About A3 & the “Why I Automate” Series:

The Association for Advancing Automation (A3) has launched a new website, www.a3automate.org. This blog-based website will tell the real story about companies that are successful because of automation, and how automation makes a positive impact on society.

The Association for Advancing Automation is the global advocate for the benefits of automating. A3 promotes automation technologies and ideas that transform the way business is done. A3 is the umbrella group for Robotic Industries Association (RIA), AIA - Advancing Vision + Imaging, and Motion Control Association (MCA). RIA, AIA, and MCA combined represent 750 automation manufacturers, component suppliers, system integrators, end users, research groups and consulting firms from throughout the world that drive automation forward.

The content & opinions in this article are the author’s and do not necessarily represent the views of RoboticsTomorrow

Comments (0)

This post does not have any comments. Be the first to leave a comment below.


Post A Comment

You must be logged in before you can post a comment. Login now.

Featured Product

BLE2 Series Brushless Motor & Driver

BLE2 Series Brushless Motor & Driver

The BLE2 Series replaces our popular BLE Series and continues our brushless motor advantages by featuring an all new compact, high-power and high-efficiency brushless DC motor combined with a Driver that can be digitally set and controlled via external DC voltage or by the front panel. The BLE2 Series can easily compete with larger 3-phase inverter driven motors in many more applications, with built-in simple holding torque function, saving space and increasing performance thanks to the advantages of a brushless motor design. The BLE2 Series has a maximum speed of 4000 r/min, achieving a speed ratio of 1:50 (80 to 4000 r/min). The new motor structure is small than previous models and enables high power and high efficiency while incorporating easy setting, installation and wiring. The new motor connector offers IP66 degree of protection and allows for easy and direct connection between motor and driver with two available orientation of cable outlet direction. Standardized use of stain